Table 2.
Citation | Study Design | Comparison (C) | Intervention (I) | Sero-conversions/Person years; Incidence rate per 100 Person Years | Unadjusted and Adjusted Results (I versus C) (95% confidence intervals) | Interpretation |
---|---|---|---|---|---|---|
A. Sites receiving HCT versus sites not receiving HCT | ||||||
| ||||||
Corbett et al., 2007 | cluster randomised controlled trial | Pre-test counselling, risk assessment, and a voucher for results and post-test counselling at a free-standing clinic; uptake 5.2% | Pre-test counselling, risk assessment, testing, results, post-test counselling, and risk reduction planning in workplace; uptake 70.7% | C: 25/2462; 0.95 (mean/cluster) I: 36/2560; 1.37 (mean/cluster) |
IRR: 1.44 (0.79, 2.80), p=0.4 aIRR: 1.49 (0.77, 2.71), p=0.5 |
no effect of HCT on HIV acquisition |
| ||||||
B. Individuals receiving HCT versus individuals not receiving HCT | ||||||
| ||||||
Machekano et al., 1998 | pre/post cohort | Pre-test counselling, tested for HIV but did not receive HIV test results or post-test counselling. | Pre-test counselling, tested for HIV, and received results and post-test counselling. | C:16/332; 4.82 I: 20/657; 3.04 |
IRR: 0.63 (0.31, 1.30), p=0.2 | trend towards HCT leading to lower HIV acquisition |
| ||||||
Matovu et al., 2005 | exposed/unexposed cohort | Participants who provided blood but did not receive HIV test results and post-test counselling at the first household survey. | Participants who provided blood and received HIV test results and post-test counselling at the first household survey. | C: 35/2441; 1.4(overall) I: 42/2631; 1.6 (overall) C: 11/1001; 1.1 (males) I: 18/1166 1.5 (males) C: 24/1439; 1.7 (females) I: 24/1464; 1.6 (females) |
IRR:1.11 (0.71, 1.75), p=0.6 (overall)** IRR: 1.40 (0.67, 3.08), p=0.4 (males)** IRR: 0.98 (0.55, 1.74), p>0.9 (females)** |
no effect of HCT on HIV acquisition |
| ||||||
Matovu et al., 2007 | exposed/unexposed cohort | Participants who did not accept home-based HCT results. (Entire population) | Participants who received home-based HCT results once or more than once (Entire population) | C: 66/4038; 1.6 (never) I: 76/4658; 1.6 (once); I: 48/3488; 1.4 (repeat) |
IRR: 1.00 (0.72, 1.39), p>0.9 (once v. never)** aIRR: 1.00 (0.72, 1.39) (once v. never) IRR: 0.84 (0.58, 1.22), p=0.4 (once v. never)** aIRR: 0.85 (0.58, 1.23) (repeat v. never) |
no effect of HCT on HIV acquisition |
Participants who did not accept home-based HCT results. (Those with ≥2 partners) | Participants who received home-based HCT results once or more than once (Those with >2 partners) | C: 16/560; 2.9 (never) I: 9/631; 1.4 (once) I: 7.641; 1.1 (repeat) |
IRR: 0.50, (0.21, 1.12), p=0.1 (once v. never)** aIRR: 0.58 (0.25, 1.37) (once v. never) IRR: 0.38, (0.15, 0.91), 0.03 (repeat v. never)** aIRR: 0.49 (0.21, 1.17) (repeat v. never) |
trend towards HCT leading to lower HIV acquisition | ||
Participants who did not accept home-based HCT results. (Those with only 1 partner) | Participants who received home-based HCT results once or more than once (Those with only 1 partner) | C: 50/3478; 1.4 (never) I: 67/4027; 1.7 (once) I: 41/2846; 1.4 (repeat) |
IRR: 1.16, (0.80, 1.67), p=0.4 (once v. never)** aIRR: 1.15, (0.79, 1.67) (once v. never) IRR: 1.00, (0.66, 1.51), p>0.9 (repeat v. never)** aIRR: 1.00 (0.66, 1.51) (repeat v. never) |
no effect of HCT on HIV acquisition | ||
| ||||||
Sherr et al., 2007 | exposed/unexposed cohort | Persons who had never been tested or counseled | Participants who received pre-test counselling, testing, and post-test counselling | C: 147/8401; 1.75 (overall) I: 18/801; 2.25 (overall) C: 61/2950; 2.07 (males) I: 10/462; 2.16 (males) C: 86/5451; 1.58 (females) I: 8/339; 2.36 (females) |
IRR: 1.28 (0.77, 2.05), p=0.3 (overall)** aIRR: 1.30 (0.79, 2.14) (overall) IRR: 1.05 (0.51, 1.98), p=0.9 (males)** aIRR: 1.08 (0.62, 1.82) (males) IRR: 1.50 (0.68, 2.95), p=0.3 (females)** aIRR: 1.55 (0.63, 3.84) (females) |
no effect of HCT on HIV acquisition |
| ||||||
Rosenberg et al., 2013 | exposed/unexposed and pre/post cohort | Participants who had not been tested for HIV and learned their results | Participants who been tested for HIV and learned their results | C: 131/4702; 2.79 I: 117/3834; 3.05 |
HR: 1.02 (95% CI: 0.79, 1.31), p=0.5 aHR: 0.65 (95% CI: 0.50, 0.86), p<0.01 ipwHR: 0.59 (95% CI: 0.45, 0.78), p<0.01 |
HCT leads to lower HIV acquisition, but only after adjustment |
| ||||||
C. Individuals receiving HCT alone versus individuals receiving HCT as a couple | ||||||
| ||||||
Allen et al., 1992 | pre/post cohort | HIV-uninfected women before undergoing couple HCT | HIV-uninfected women after undergoing couple HCT | HCT: 12/293 4.1* cHCT: 5/278; 1.8* |
IRR: 0.44 (0.14, 1.22), p=0.1** | trend towards cHCT being more protective than no HCT |
exposed/unexposed cohort | HIV-uninfected women who underwent individual HCT | HIV-uninfected women who underwent couple HCT | HCT: 24/706; 3.4* cHCT: 5/278; 1.8 |
IRR: 0.53 (0.18, 1.32), p=0.2** | trend towards cHCT being more protective than individual HCT | |
| ||||||
Okiria et al., 2013 | exposed/unexposed cohort | Individual pre- and post-test counselling | Couple pre- and post-test counselling | HCT: 82/NA; 0.81 cHCT: 24NA; 0.25 HCT: 27/NA; 0.85 (women) cHCT 3/NA; 0.14 (women)*** HCT: 11/NA; 0.76 (men) cHCT: 7/NA; 0.38 (men) |
IRR: 0.31 (0.19, 0.48), p<0.01** IRR: 0.4 (0.22–0.75), p=<0.01 (women) aIRR: 0.4 (0.22–0.75) (women) IRR: 0.5 (0.24–1.05), p=0.07 (men) |
cHCT was more protective than individual HCT. |
based on hand calculations by the review authors.
confidence intervals calculated by review authors using Open Epi
Review authors believe original article may not have correctly reported this strata as the hand-calculated incidence rate ratio does not equal the reported rate ratio and the person years seem insufficient.
HCT=HIV counselling and testing; cHCT=couple HIV counselling and testing; C=comparison; I=intervention; IRR=incidence rate ratio; HR=hazard ratio; CI=confidence interval; PY=person year; a=adjusted; ipw=inverse probability weighted; NA=not available